GALECTIN 3 AND ALDOSTERONE IN PATIENTS WITH ATRIAL FIBRILLATION AND METABOLIC SYNDROME
Aim. To study the levels of galectin 3 and aldostrone in blood serum of metabolic syndrome (MS) patients and atrial fibrillation (AF) for their importance evaluation. Material and methods. Totally 100 patients with MS (IDF, 2005) studied, of those 50 with AF: 28 with paroxysmal and 22 with persisten...
Main Authors: | V. A. lonin, A. V. Soboleva, O. V. Listopad, S. E. Nifontov, E. A. Bazhenova, E. Yu. Vasilieva, E. I. Baranova, E. V. Shlyakhto |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2015-04-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/288 |
Similar Items
-
Role of galectin 3 and epicardial fat thickness in the development of atrial fibrillation in patients with metabolic syndrome
by: V. A. Ionin, et al.
Published: (2015-03-01) -
Galectin-3, N-terminal Propeptides of Type I and III Procollagen in Patients with Atrial Fibrillation and Metabolic Syndrome
by: Valery A. Ionin, et al.
Published: (2020-08-01) -
THE ROLE OF TRANSFORMING GROWTH FACTOR BETA-1 AND GALECTIN-3 IN FORMATION OF THE LEFT ATRIUM FIBROSIS IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION AND METABOLIC SYNDROME
by: E. L. Zaslavskaya, et al.
Published: (2018-03-01) -
С(-344)Т polymorphism of aldosterone synthase gene, risk of metabolic syndrome, and atrial fibrillation risk for inhabitants of the Northwest regions of Russia
by: I. Ma, et al.
Published: (2016-06-01) -
Molecular mechanisms of left atrial fibrosis development in patients with atrial fibrillation and metabolic syndrome: what biomarkers should be used in clinical practice?
by: V. A. Ionin, et al.
Published: (2021-08-01)